Skip to Main Content

Author Details

William Matsui
Livestrong Cancer Institutes, Dell Medical School, University of Texas at Austin
1989
136
62
Prashant Mali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
38001595CD46-ADC Reduces the Engraftment of Multiple Myeloma Patient-Derived Xenografts.Cancers (Basel)2023
33960532Whole-exome sequencing identifies functional classes of gene mutations associated with bone marrow failure in pediatric Fanconi Anemia patients.Eur J Haematol2021
34638372Hedgehog Signaling in Myeloid Malignancies.Cancers (Basel)2021
32690957Organotypic culture assays for murine and human primary and metastatic-site tumors.Nat Protoc2020
32034142CD229 CAR T cells eliminate multiple myeloma and tumor propagating cells without fratricide.Nat Commun2020
30540680IQGAP1 Maintains Pancreatic Ductal Adenocarcinoma Clonogenic Growth and Metastasis.Pancreas2019
30171262Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity.Oncogene2019
31593010Biphenotypic Differentiation of Pancreatic Cancer in 3-Dimensional Culture.Pancreas2019
30830874Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.JCI Insight2019
30747824Direct Interactions With Cancer-Associated Fibroblasts Lead to Enhanced Pancreatic Cancer Stem Cell Function.Pancreas2019
30655325Ezrin Promotes Stem Cell Properties in Pancreatic Ductal Adenocarcinoma.Mol Cancer Res2019
30599208Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide.Biol Blood Marrow Transplant2019
29353109Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation.Biol Blood Marrow Transplant2018
29909152Early Fever after Haploidentical Bone Marrow Transplantation Correlates with Class II HLA-Mismatching and Myeloablation but Not Outcomes.Biol Blood Marrow Transplant2018
29669947Anti-CD19 CAR T cells with high-dose melphalan and autologous stem cell transplantation for refractory multiple myeloma.JCI Insight2018
29452245Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide Using Non-First-Degree Related Donors.Biol Blood Marrow Transplant2018
29055682Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosphamide.Biol Blood Marrow Transplant2018
27490478Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol.J Cell Biochem2017
29242852Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide.Blood Adv2017
28754545Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow Transplantation.Biol Blood Marrow Transplant2017
28692661The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.PLoS One2017
28581518Activation of tumor suppressor LKB1 by honokiol abrogates cancer stem-like phenotype in breast cancer via inhibition of oncogenic Stat3.Oncogene2017
28711728Allogeneic Blood or Marrow Transplantation with Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Multiple Myeloma.Biol Blood Marrow Transplant2017
27846611Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.Haematologica2017
28049637Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.Blood2017
26975880Donor cell leukemia arising from clonal hematopoiesis after bone marrow transplantation.Leukemia2016
26387544Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.Oncogene2016
26292764Therapeutic drug monitoring for either oral or intravenous busulfan when combined with pre- and post-transplantation cyclophosphamide.Leuk Lymphoma2016
27611937Cancer stem cell signaling pathways.Medicine (Baltimore)2016
27611936Cancer stem cells: A nuanced perspective.Medicine (Baltimore)2016
27775549Hedgehog and retinoid signaling alters multiple myeloma microenvironment and generates bortezomib resistance.J Clin Invest2016
27619199Differentiation therapy in poor risk myeloid malignancies: Results of companion phase II studies.Leuk Res2016
27573425IQGAP1 Scaffold-MAP Kinase Interactions Enhance Multiple Myeloma Clonogenic Growth and Self-Renewal.Mol Cancer Ther2016
25814532Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide.Blood2015
26261255Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults.J Clin Oncol2015
26183076Phase II Study of Nonmyeloablative Allogeneic Bone Marrow Transplantation for B Cell Lymphoma with Post-Transplantation Rituximab and Donor Selection Based First on Non-HLA Factors.Biol Blood Marrow Transplant2015
25995224Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma.Sci Transl Med2015
24096005DCLK1 marks a morphologically distinct subpopulation of cells with stem cell properties in preinvasive pancreatic cancer.Gastroenterology2014
25316679Single-agent GVHD prophylaxis with posttransplantation cyclophosphamide after myeloablative, HLA-matched BMT for AML, ALL, and MDS.Blood2014
25012565Granulocyte-macrophage colony stimulating factor (GM-CSF) enhances the clinical responses to interferon-α (IFN) in newly diagnosed chronic myeloid leukemia (CML).Leuk Res2014
24807964Activation of liver X receptors inhibits hedgehog signaling, clonogenic growth, and self-renewal in multiple myeloma.Mol Cancer Ther2014
24345755Growth differentiating factor 15 enhances the tumor-initiating and self-renewal potential of multiple myeloma cells.Blood2014
24290285Associations between serum folate and vitamin D levels and incident mouse sensitization in adults.J Allergy Clin Immunol2014
24463449NRF2-mediated Notch pathway activation enhances hematopoietic reconstitution following myelosuppressive radiation.J Clin Invest2014
22835045Brief intensive therapy for older adults with newly diagnosed Burkitt or atypical Burkitt lymphoma/leukemia.Leuk Lymphoma2013
24332045A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer.Cancer Cell2013
23871780Absence of post-transplantation lymphoproliferative disorder after allogeneic blood or marrow transplantation using post-transplantation cyclophosphamide as graft-versus-host disease prophylaxis.Biol Blood Marrow Transplant2013
23580570Single copies of mutant KRAS and mutant PIK3CA cooperate in immortalized human epithelial cells to induce tumor formation.Cancer Res2013
23530114Tumorigenic potential of circulating prostate tumor cells.Oncotarget2013
23586700Cancer stem cells in lung cancer: Evidence and controversies.Respirology2013
  • 1 - 50 of 136

Recommended Authors

Radek Fedr
Institute of Biophysics of the Czech Academy of Sciences
Career Start Year 2013
Number of shared co-authors 0
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 1
Faiyaz Notta
2Ontario Institute for Cancer Research
Career Start Year 2009
Number of shared co-authors 4
Yang Chen
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 1
Anupriya Agarwal
Knight Cancer Institute, Oregon Health & Science University
Career Start Year 2006
Number of shared co-authors 1
Christopher Y Park
NYU Robert I. Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 1
Fumio Nakahara
Graduate School of Medicine, The University of Tokyo
Career Start Year 2004
Number of shared co-authors 0
Donghui Cheng
University of California los angeles
Career Start Year 2003
Number of shared co-authors 0
Christopher R Cogle
College of Medicine, University of Florida
Career Start Year 2003
Number of shared co-authors 2
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Phillip M Clair
Huntsman Cancer Institute, The University of Utah
Career Start Year 2001
Number of shared co-authors 0
Andrea Viale
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 2
Qingxia Wei
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Career Start Year 2000
Number of shared co-authors 1
David J Liewehr
Center for Cancer Research
Career Start Year 1999
Number of shared co-authors 1
Ravindra Majeti
Stanford University School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Maura Gasparetto
University of Colorado School of Medicine
Career Start Year 1998
Number of shared co-authors 0
Jan Paul Medema
Oncode Institute
Career Start Year 1993
Number of shared co-authors 0
Craig Gedye
Hunter Medical Research Institute, University of Newcastle
Career Start Year 1993
Number of shared co-authors 1
Michael W Becker
James P. Wilmot Cancer Institute, University of Rochester Medical Center Rochester
Career Start Year 1992
Number of shared co-authors 2
Ravi Bhatia
University of Alabama at Birmingham
Career Start Year 1992
Number of shared co-authors 2
James DeGregori
University of Colorado Anschutz Medical Campus
Career Start Year 1991
Number of shared co-authors 0
Jana Krosl
The Leucegene Project at Institute for Research in Immunology and Cancer.
Career Start Year 1989
Number of shared co-authors 0
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 7
Suzanne Kamel-Reid
Toronto General Hospital, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 2
Guy Sauvageau
Universite de Montreal
Career Start Year 1988
Number of shared co-authors 0
Clayton A Smith
University of Colorado, Aurora CO.
Career Start Year 1987
Number of shared co-authors 1
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 10
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Career Start Year 1986
Number of shared co-authors 3
John E Dick
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1980
Number of shared co-authors 4
Wolfgang E Berdel
University Hospital Munster
Career Start Year 1976
Number of shared co-authors 0

Collaborators

Richard J Jones
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 53
Robert A Brodsky
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers 32
Anirban Maitra
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
Christopher D Gocke
Johns Hopkins University School of Medicine
Co-authored papers 8
Mark J Levis
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 7
David M Berman
Queen's University
Co-authored papers 5
Charles G Eberhart
Wilmer Eye Institute, Johns Hopkins Medical Institutions
Co-authored papers 5
David N Watkins
Research Institute in Oncology and Hematology
Co-authored papers 5
Luigi Marchionni
Weill-Cornell School of Medicine
Co-authored papers 4
Antonio Jimeno
University of Colorado School of Medicine
Co-authored papers 3
Stephen B Baylin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Co-authored papers 3
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Co-authored papers 3
Tara L Lin
University of Kansas Medical Center
Co-authored papers 3
Leander Van Neste
Maastricht University Medical Center
Co-authored papers 3
Aykut Uren
Georgetown University Medical Center
Co-authored papers 2
Pedram Argani
The Johns Hopkins Hospital
Co-authored papers 2
Alana L Welm
Huntsman Cancer Institute, University of Utah
Co-authored papers 2
Joyce E Ohm
Roswell Park Comprehensive Cancer Center
Co-authored papers 2
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers 2
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Co-authored papers 2
Feyruz V Rassool
University of Maryland Greenebaum Comprehensive Cancer Center
Co-authored papers 2
Yue-Ming Li
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Francesco DiMeco
Co-authored papers 2
Jonathan A Pachter
Laufer Center for Physical and Quantitative Biology, Stony Brook University
Co-authored papers 2
Carl H June
University of Pennsylvania Department of Pathology & Laboratory Medicine
Co-authored papers 2
Angelo L Vescovi
IRCCS Casa Sollievo della Sofferenza, University of Milano-Bicocca
Co-authored papers 2
Linzhao Cheng
Johns Hopkins University School of Medicine
Co-authored papers 2
Wayne Yu
Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Co-authored papers 2
Ben Ho Park
Vanderbilt University Medical Center
Co-authored papers 2
Emmanuel S Antonarakis
The Sidney Kimmel Cancer Comprehensive Cancer Center at Johns Hopkins
Co-authored papers 1
Release 1.2